Skip to main content
SpringerLink
Log in

Regionale Chemotherapie/Chemoembolisation von Lebermetastasen

  • Living reference work entry
  • First Online:
Kompendium Internistische Onkologie

Part of the book series: Springer Reference Medizin ((SRM))

  • 30 Accesses

Zusammenfassung

Regionale Therapieverfahren werden zur gezielten Behandlung eines tumor- oder metastasentragenden Organs oder Organsystems eingesetzt. Sie werden einerseits von den lokalen (z. B. chirurgischen oder ablativen) Techniken, andererseits der medikamentösen Systemtherapie abgegrenzt. Im Bereich der internistischen und chirurgischen Onkologie besitzen vor allem die regionalen intravasalen (z. B. über die Arteria hepatica) und intrakavitären Applikationen antineoplastischer Medikamente einen Stellenwert. Im vorliegenden Kapitel werden die regionalen Chemotherapieverfahren der Leber sowie die transarterielle Chemoembolisation besprochen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

Literatur

  • Agarwala SS, Panikkar R, Kirkwood JM (2004) Phase I/II randomized trial of intrahepatic arterial infusion chemotherapy with cisplatin and chemoembolization with cisplatin and polyvinyl sponge in patients with ocular melanoma metastatic to the liver. Melanoma Res 14(3):217–222

    Article  CAS  PubMed  Google Scholar 

  • Akinwande O, Dendy M, Ludwig JM, Kim HS (2017) Hepatic intra-arterial injection of irinotecan drug eluting beads (DEBIRI) for patients with unresectable colorectal liver metastases: a systematic review. Surg Oncol 26(3):268–275

    Article  PubMed  Google Scholar 

  • Albert M, Kiefer MV, Sun W, Haller D, Fraker DL, Tuite CM et al (2011) Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol. Cancer 117(2):343–352

    Article  CAS  PubMed  Google Scholar 

  • Aliberti C, Fiorentini G, Muzzio PC, Pomerri F, Tilli M, Dallara S et al (2011) Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead(R), drug-eluting bead loaded with irinotecan: results of a phase II clinical study. Anticancer Res 31(12):4581–4587

    CAS  PubMed  Google Scholar 

  • Allen PJ, Nissan A, Picon AI, Kemeny N, Dudrick P, Ben-Porat L et al (2005) Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases. J Am Coll Surg 201(1):57–65

    Article  PubMed  Google Scholar 

  • Baere T de, Tselikas L, Boige V, Ducreux M, Malka D, Goere D et al (2017) Intra-arterial therapies for colorectal cancer liver metastases (radioembolization excluded). Bull Cancer 104(5):402–406

    Google Scholar 

  • Bhutiani N, Akinwande O, Martin RC 2nd. (2016) Efficacy and toxicity of hepatic intra-arterial drug-eluting (irinotecan) bead (DEBIRI) therapy in irinotecan-refractory unresectable colorectal liver metastases. World J Surg 40(5):1178–1190

    Article  PubMed  Google Scholar 

  • Breedis C, Young G (1954) The blood supply of neoplasms in the liver. Am J Pathol 30(5):969–977

    CAS  PubMed  PubMed Central  Google Scholar 

  • Brown KT, Do RK, Gonen M, Covey AM, Getrajdman GI, Sofocleous CT et al (2016) Randomized trial of hepatic artery embolization for hepatocellular carcinoma using doxorubicin-eluting microspheres compared with embolization with microspheres alone. J Clin Oncol 34(17):2046–2053

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cao G, Zhu X, Li J, Shen L, Yang R, Chen H et al (2014) A comparative study between Embosphere((R)) and conventional transcatheter arterial chemoembolization for treatment of unresectable liver metastasis from GIST. Chin J Cancer Res 26(1):124–131

    PubMed  PubMed Central  Google Scholar 

  • Carrasco CH, Wallace S, Charnsangavej C, Papadopoulos NE, Patt YZ, Mavligit GM (1986) Treatment of hepatic metastases in ocular melanoma. Embolization of the hepatic artery with polyvinyl sponge and cisplatin. JAMA 255(22):3152–3154

    Article  CAS  PubMed  Google Scholar 

  • Carvajal RD, Schwartz GK, Tezel T, Marr B, Francis JH, Nathan PD (2017) Metastatic disease from uveal melanoma: treatment options and future prospects. Br J Ophthalmol 101(1):38–44

    Article  PubMed  Google Scholar 

  • Cohen AD, Kemeny NE (2003) An update on hepatic arterial infusion chemotherapy for colorectal cancer. Oncologist 8(6):553–566

    Article  PubMed  Google Scholar 

  • De Groote K, Prenen H (2015) Intrahepatic therapy for liver-dominant metastatic colorectal cancer. World J Gastrointest Oncol 7(9):148–152

    Article  PubMed  PubMed Central  Google Scholar 

  • Deutsche Gesellschaft für Gastroenterologie V-uS, Netzwerk Neuroendokrine Tumoren e. V., Bundesorganisation Selbsthilfe NeuroEndokrine Tumoren e. V., Deutsche Gesellschaft fur Hamatologie und Medizinische Onkologie e. V., uAIOdDKeV, Deutsche Gesellschaft fur Allgemein- und Viszeralchirurgie e. V., Deutsche Gesellschaft fur C et al (2018) S2k-Leitlinie Neuroendokrine Tumore – AWMF-Reg. 021–27. Z Gastroenterol 56(6):583–681

    Google Scholar 

  • Dhir M, Shrestha R, Steel JL, Marsh JW, Tsung A, Tublin ME et al (2017) Initial treatment of unresectable neuroendocrine tumor liver metastases with transarterial chemoembolization using streptozotocin: a 20-year experience. Ann Surg Oncol 24(2):450–459

    Article  PubMed  Google Scholar 

  • Dominguez S, Denys A, Madeira I, Hammel P, Vilgrain V, Menu Y et al (2000) Hepatic arterial chemoembolization with streptozotocin in patients with metastatic digestive endocrine tumours. Eur J Gastroenterol Hepatol 12(2):151–157

    Article  CAS  PubMed  Google Scholar 

  • Dong XD, Carr BI (2011) Hepatic artery chemoembolization for the treatment of liver metastases from neuroendocrine tumors: a long-term follow-up in 123 patients. Med Oncol 28(Suppl 1):S286–S290

    Article  PubMed  Google Scholar 

  • Eichler K, Zangos S, Mack MG, Hammerstingl R, Gruber-Rouh T, Gallus C et al (2012) First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI). Int J Oncol 41(4):1213–1220

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ensminger WD (2002) Intrahepatic arterial infusion of chemotherapy: pharmacologic principles. Semin Oncol 29(2):119–125

    Article  CAS  PubMed  Google Scholar 

  • European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the Liver (2018) EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol 69(1):182–236

    Article  Google Scholar 

  • Facciorusso A, Mariani L, Sposito C, Spreafico C, Bongini M, Morosi C et al (2016) Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma. J Gastroenterol Hepatol 31(3):645–653

    Article  CAS  PubMed  Google Scholar 

  • Fiore F, Del Prete M, Franco R, Marotta V, Ramundo V, Marciello F et al (2014) Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors. Endocrine 47(1):177–182

    Article  CAS  PubMed  Google Scholar 

  • Fiorentini G, Aliberti C, Del Conte A, Tilli M, Rossi S, Ballardini P et al (2009) Intra-arterial hepatic chemoembolization (TACE) of liver metastases from ocular melanoma with slow-release irinotecan-eluting beads. Early results of a phase II clinical study. In Vivo 23(1):131–137

    PubMed  Google Scholar 

  • Fiorentini G, Aliberti C, Tilli M, Mulazzani L, Graziano F, Giordani P et al (2012) Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study. Anticancer Res 32(4):1387–1395

    CAS  PubMed  Google Scholar 

  • Fleckenstein FN, Schernthaner RE, Duran R, Sohn JH, Sahu S, Marshall K et al (2016) Renal cell carcinoma metastatic to the liver: early response assessment after intraarterial therapy using 3D quantitative tumor enhancement analysis. Transl Oncol 9(5):377–383

    Article  PubMed  PubMed Central  Google Scholar 

  • Gates J, Hartnell GG, Stuart KE, Clouse ME (1999) Chemoembolization of hepatic neoplasms: safety, complications, and when to worry. Radiographics 19(2):399–414

    Article  CAS  PubMed  Google Scholar 

  • Glazer ES, Zager JS (2017) Chemosaturation with percutaneous hepatic perfusion in unresectable hepatic metastases. Cancer Control 24(1):96–101

    Article  PubMed  Google Scholar 

  • Golfieri R, Giampalma E, Renzulli M, Cioni R, Bargellini I, Bartolozzi C et al (2014) Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma. Br J Cancer 111(2):255–264

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gordon AC, Uddin OM, Riaz A, Salem R, Lewandowski RJ (2017) Making the case: intra-arterial therapy for less common metastases. Semin Interv Radiol 34(2):132–139

    Article  Google Scholar 

  • Hama Y, Kusano S (2005) Liver abscess formation after hepatic chemoembolization for metastatic pancreatic neuroendocrine tumor. Minim Invasive Ther Allied Technol 14(1):6–7

    Article  CAS  PubMed  Google Scholar 

  • Harmantas A, Rotstein LE, Langer B (1996) Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver. Is there a survival difference? Meta-analysis of the published literature. Cancer 78(8):1639–1645

    Article  CAS  PubMed  Google Scholar 

  • Heinrich S, Petrowsky H, Schwinnen I, Staib-Sebler E, Gog C, El-Ganainy A et al (2003) Technical complications of continuous intra-arterial chemotherapy with 5-fluorodeoxyuridine and 5-fluorouracil for colorectal liver metastases. Surgery 133(1):40–48

    Article  PubMed  Google Scholar 

  • Hildebrandt B, Pech M, Nicolaou A, Langrehr JM, Kurcz J, Bartels B et al (2007) Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with colorectal liver metastases: a Phase II-study and historical comparison with the surgical approach. BMC Cancer 7:69

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Hong K, McBride JD, Georgiades CS, Reyes DK, Herman JM, Kamel IR et al (2009) Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization. J Vasc Interv Radiol: JVIR 20(3):360–367

    Article  PubMed  Google Scholar 

  • https://www.leitlinienprogramm.onkologie.de/leitlinien/kolorektales-karzinom

  • Hughes MS, Zager J, Faries M, Alexander HR, Royal RE, Wood B et al (2016) Results of a randomized controlled multicenter phase III trial of percutaneous hepatic perfusion compared with best available care for patients with melanoma liver metastases. Ann Surg Oncol 23(4):1309–1319

    Article  PubMed  Google Scholar 

  • Huppert P, Wenzel T, Wietholtz H (2014) Transcatheter arterial chemoembolization (TACE) of colorectal cancer liver metastases by irinotecan-eluting microspheres in a salvage patient population. Cardiovasc Intervent Radiol 37(1):154–164

    Article  PubMed  Google Scholar 

  • Jonczyk M, Collettini F, Schnapauff D, Geisel D, Boning G, Ludemann WM et al (2019) Visibility of hypovascularized liver tumors during intra-arterial therapy using split-bolus single-phase cone beam CT. Cardiovasc Intervent Radiol 42(2):260–267

    Article  PubMed  Google Scholar 

  • Jones RP, Malik HZ, Fenwick SW, Terlizzo M, O'Grady E, Stremitzer S et al (2016) PARAGON II – a single arm multicentre phase II study of neoadjuvant therapy using irinotecan bead in patients with resectable liver metastases from colorectal cancer. Eur J Surg Oncol 42(12):1866–1872

    Article  CAS  PubMed  Google Scholar 

  • Karalli A, Ghaffarpour R, Axelsson R, Lundell L, Bozoki B, Brismar T et al (2017) Transarterial chemoembolization of renal cell carcinoma: a prospective controlled trial. J Vasc Interv Radiol: JVIR 28(12):1664–1672

    Article  PubMed  Google Scholar 

  • Kelly CM, Kemeny NE (2017) Liver-directed therapy in metastatic colorectal cancer. Expert Rev Anticancer Ther 17(8):745–758

    Article  CAS  PubMed  Google Scholar 

  • Kemeny MM (2001) The surgical aspects of the totally implantable hepatic artery infusion pump. Arch Surg 136(3):348–352

    Article  CAS  PubMed  Google Scholar 

  • Kemeny N, Huang Y, Cohen AM, Shi W, Conti JA, Brennan MF et al (1999) Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341(27):2039–2048

    Article  CAS  PubMed  Google Scholar 

  • Kemeny NE, Gonen M (2005) Hepatic arterial infusion after liver resection. N Engl J Med 352(7):734–735

    Article  CAS  PubMed  Google Scholar 

  • Kemeny NE, Niedzwiecki D, Hollis DR, Lenz HJ, Warren RS, Naughton MJ et al (2006) Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 24(9):1395–1403

    Article  CAS  PubMed  Google Scholar 

  • Kemeny NE, Melendez FD, Capanu M, Paty PB, Fong Y, Schwartz LH et al (2009) Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. J Clin Oncol 27(21):3465–3471

    Article  PubMed  PubMed Central  Google Scholar 

  • Kerr DJ, McArdle CS, Ledermann J, Taylor I, Sherlock DJ, Schlag PM et al (2003) Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. Lancet 361(9355):368–373

    Article  CAS  PubMed  Google Scholar 

  • Kloeckner R, Weinmann A, Prinz F, Pinto dos Santos D, Ruckes C, Dueber C et al (2015) Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma. BMC Cancer 15:465

    Article  PubMed  PubMed Central  Google Scholar 

  • Kudo M, Ueshima K, Yokosuka O, Ogasawara S, Obi S, Izumi N et al (2018) Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial. Lancet Gastroenterol Hepatol 3(6):424–432

    Article  PubMed  Google Scholar 

  • Leichman CG, Jacobson JR, Modiano M, Daniels JR, Zalupski MM, Doroshow JH et al (1999) Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: a Southwest Oncology Group pilot trial. Cancer 86(5):775–781

    Article  CAS  PubMed  Google Scholar 

  • Levi FA, Boige V, Hebbar M, Smith D, Lepere C, Focan C et al (2016) Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV. Ann Oncol 27(2):267–274

    Article  CAS  PubMed  Google Scholar 

  • Leyvraz S, Piperno-Neumann S, Suciu S, Baurain JF, Zdzienicki M, Testori A et al (2014) Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial. Ann Oncol 25(3):742–746

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liu DM, Thakor AS, Baerlocher M, Alshammari MT, Lim H, Kos S et al (2015a) A review of conventional and drug-eluting chemoembolization in the treatment of colorectal liver metastases: principles and proof. Future Oncol 11(9):1421–1428

    Article  CAS  PubMed  Google Scholar 

  • Liu W, Song QK, Xing BC (2015b) A systematic review and meta-analysis to reappraise the role of adjuvant hepatic arterial infusion for colorectal cancer liver metastases. Int J Color Dis 30(8):1091–1102

    Article  Google Scholar 

  • Lorenz M, Muller HH (2000) Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol 18(2):243–254

    Article  CAS  PubMed  Google Scholar 

  • Marcacuzco Quinto A, Nutu OA, San Roman Manso R, Justo Alonso I, Calvo Pulido J, Manrique Municio A et al (2018) Complications of transarterial chemoembolization (TACE) in the treatment of liver tumors. Cir Esp 96(9):560–567

    Article  PubMed  Google Scholar 

  • Martin RC, Robbins K, Tomalty D, O'Hara R, Bosnjakovic P, Padr R et al (2009) Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report. World J Surg Oncol 7:80

    Article  PubMed  PubMed Central  Google Scholar 

  • Meta-Analysis Group in Cancer, Piedbois P, Buyse M, Kemeny N, Rougier P, Carlson R et al (1996) Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 88(5):252–258

    Article  Google Scholar 

  • Mocellin S, Pilati P, Lise M, Nitti D (2007) Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era? J Clin Oncol 25(35):5649–5654

    Article  PubMed  Google Scholar 

  • Muller H, Nakchbandi V, Chatzisavvidis I, von Voigt C (2003) Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases. Hepato-Gastroenterology 50(54):1919–1926

    CAS  PubMed  Google Scholar 

  • Nabil M, Gruber T, Yakoub D, Ackermann H, Zangos S, Vogl TJ (2008) Repetitive transarterial chemoembolization (TACE) of liver metastases from renal cell carcinoma: local control and survival results. Eur Radiol 18(7):1456–1463

    Article  PubMed  Google Scholar 

  • Narayanan G, Barbery K, Suthar R, Guerrero G, Arora G (2013) Transarterial chemoembolization using DEBIRI for treatment of hepatic metastases from colorectal cancer. Anticancer Res 33(5):2077–2083

    CAS  PubMed  Google Scholar 

  • Nitti D, Wils J, Sahmoud T, Curran D, Couvreur ML, Lise M et al (1997) Final results of a phase III clinical trial on adjuvant intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC GITCCG 1983–1987). European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group. Eur J Cancer 33(8):1209–1215

    Article  CAS  PubMed  Google Scholar 

  • Pavel M, Baudin E, Couvelard A, Krenning E, Oberg K, Steinmuller T et al (2012) ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology 95(2):157–176

    Article  CAS  PubMed  Google Scholar 

  • Pelage JP, Fohlen A, Mitry E, Lagrange C, Beauchet A, Rougier P (2017) Chemoembolization of neuroendocrine liver metastases using streptozocin and tris-acryl microspheres: embozar (EMBOsphere + ZAnosaR) study. Cardiovasc Intervent Radiol 40(3):394–400

    Article  PubMed  Google Scholar 

  • Pitt SC, Knuth J, Keily JM, McDermott JC, Weber SM, Chen H et al (2008) Hepatic neuroendocrine metastases: chemo- or bland embolization? J Gastrointest Surg 12(11):1951–1960

    Article  PubMed  PubMed Central  Google Scholar 

  • Poggi G, Quaretti P, Minoia C, Bernardo G, Bonora MR, Gaggeri R et al (2008) Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors. Anticancer Res 28(6B):3835–3842

    CAS  PubMed  Google Scholar 

  • Ricke J, Hildebrandt B, Miersch A, Nicolaou A, Warschewske G, Teichgraber U et al (2004) Hepatic arterial port systems for treatment of liver metastases: factors affecting patency and adverse events. J Vasc Interv Radiol: JVIR 15(8):825–833

    Article  PubMed  Google Scholar 

  • Rostas JW, Tam AL, Sato T, Scoggins CR, McMasters KM, Martin RCG 2nd. (2017) Health-related quality of life during trans-arterial chemoembolization with drug-eluting beads loaded with doxorubicin (DEBDOX) for unresectable hepatic metastases from ocular melanoma. Am J Surg 214(5):884–890

    Article  PubMed  Google Scholar 

  • Salman HS, Cynamon J, Jagust M, Bakal C, Rozenblit A, Kaleya R et al (2002) Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver. Clin Colorectal Cancer 2(3):173–179

    Article  CAS  PubMed  Google Scholar 

  • Sato T (2010) Locoregional management of hepatic metastasis from primary uveal melanoma. Semin Oncol 37(2):127–138

    Article  PubMed  Google Scholar 

  • Scevola G, Loreni G, Rastelli M, Sposato S, Ramponi S, Miele V (2017) Third-line treatment of colorectal liver metastases using DEBIRI chemoembolization. Med Oncol 34(3):37

    Article  PubMed  CAS  Google Scholar 

  • Schalhorn A, Kuhl M (1995) Pharmacology of regional chemotherapy of colorectal liver metastases. Zentralbl Chir 120(10):764–768

    Google Scholar 

  • Sinn M, Nicolaou A, Ricke J, Podrabsky P, Seehofer D, Gebauer B et al (2013) Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with primary liver cancer: a phase II-study (NCT00356161). BMC Gastroenterol 13:125

    Article  PubMed  PubMed Central  Google Scholar 

  • Starke A, Saddig C, Mansfeld L, Koester R, Tschahargane C, Czygan P et al (2005) Malignant metastatic insulinoma-postoperative treatment and follow-up. World J Surg 29(6):789–793

    Article  PubMed  Google Scholar 

  • Tellez C, Benson AB 3rd, Lyster MT, Talamonti M, Shaw J, Braun MA et al (1998) Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer 82(7):1250–1259

    Article  CAS  PubMed  Google Scholar 

  • Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D et al (2016) ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol 27(8):1386–1422

    Google Scholar 

  • Vogel A, Gupta S, Zeile M, von Haken R, Bruning R, Lotz G et al (2017) Chemosaturation percutaneous hepatic perfusion: a systematic review. Adv Ther 33(12):2122–2138

    Article  CAS  PubMed  Google Scholar 

  • Vogel A, Cervantes A, Chau I, Daniele B, Llovet J, Meyer T et al (2018) Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29(Suppl_4):iv238–iv255

    Article  CAS  PubMed  Google Scholar 

  • Vogl TJ, Gruber T, Balzer JO, Eichler K, Hammerstingl R, Zangos S (2009) Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study. Radiology 250(1):281–289

    Article  PubMed  Google Scholar 

  • Weh HJ, Wilke HJ, Dierlamm J, Klaassen U, Siegmund R, Illiger HJ et al (1994) Weekly therapy with folinic acid (FA) and high-dose 5-fluorouracil (5-FU) 24-hour infusion in pretreated patients with metastatic colorectal carcinoma. A multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO). Ann Oncol 5(3):233–237

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chefarzt Medizinische Klinik 1, GLG Werner Forßmann Klinikum, Eberswalde, Deutschland

    Bert Hildebrandt

  2. Klinik für Radiologie, Charité, Campus Virchow-Klinikum, Berlin, Deutschland

    Bernhard Gebauer

Authors
  1. Bert Hildebrandt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bernhard Gebauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bert Hildebrandt .

Editor information

Editors and Affiliations

  1. Abt. Hämatologie und Onkologie, Universitätsklinikum Halle-Wittenberg Klinik und Poliklinik Innere Medizin IV, Halle, Sachsen-Anhalt, Deutschland

    Hans-Joachim Schmoll

Section Editor information

  1. No affiliation provided

    Hans-Joachim Schmoll

  2. No affiliation provided

    Jens Ricke

  3. No affiliation provided

    Bernhard Gebauer

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Hildebrandt, B., Gebauer, B. (2022). Regionale Chemotherapie/Chemoembolisation von Lebermetastasen. In: Schmoll, HJ. (eds) Kompendium Internistische Onkologie . Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46764-0_187-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-46764-0_187-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-46764-0

  • Online ISBN: 978-3-662-46764-0

  • eBook Packages: Springer Referenz Medizin

Publish with us

Policies and ethics

Search

Navigation